1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs

Daugherty, B. L., Boohaker, R. J., Johnstone, R., Stinson, K., Zhao, G., Zang, M., Qian, J., Wang, T. C., & Lederman, S. (2023). 1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.1345
Authors:
Bruce L. Daugherty
Rebecca J. Boohaker
Rebecca Johnstone
Karr Stinson
Grace Zhao
Mingfa Zang
Jin Qian
Timothy C. Wang
Seth Lederman
Affiliated Authors:
Jin Qian
Timothy C. Wang
Subjects:
Macrophage Activation and Polarization (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2023-sitc2023.1345
DOI:
10.1136/jitc-2023-sitc2023.1345
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: